Hoshi Iryo-Sanki (7634) Q4 2026 earnings summary

Executive summary

• FY ended Mar 2026 revenue rose 2.8% to ¥15,520m, while operating income fell 3.2% and net income attributable to owners of the parent fell 6.2%.

• Operating margin was 12.4%, above the stated 12% KPI threshold; the equity ratio was 74.8%.

• Priorities included stable supply, safety, and social responsibility across medical, nursing, and welfare services.

Financial highlights

• Revenue was ¥15,520m, up ¥418m YoY; gross profit was ¥7,676m, up 1.5%.

• Operating income was ¥1,919m, down 3.2%; ordinary income was ¥2,000m, down 2.5%.

• Net income attributable to owners of the parent was ¥1,372m, down 6.2%; comprehensive income was ¥1,845m, up 19.6%.

• EBITDA was ¥2,872m, up ¥66m; capital expenditures were ¥953m versus depreciation of ¥824m.

• Cash and cash equivalents at year-end were ¥5,910m.

Outlook and guidance

• FY Mar 2027 guidance: revenue ¥15,660m (+0.9%), operating income ¥1,980m (+3.2%), ordinary income ¥2,060m (+3.0%), and net income ¥1,400m (+2.0%).

• Forecast EPS is ¥448.31, up 1.9%; priorities include appropriate pricing, wider sales channels, cross-segment solutions, and operational efficiency through DX and process review.

• Plans emphasize stable medical-gas supply and improved profitability in medical-gas and home-care operations; M&A is also a growth lever.